CA2047723A1 - Compound for improving the ovary reactions and the ova and embryo production in domestic mammals in combination with biotechnological embryo transfer - Google Patents

Compound for improving the ovary reactions and the ova and embryo production in domestic mammals in combination with biotechnological embryo transfer

Info

Publication number
CA2047723A1
CA2047723A1 CA002047723A CA2047723A CA2047723A1 CA 2047723 A1 CA2047723 A1 CA 2047723A1 CA 002047723 A CA002047723 A CA 002047723A CA 2047723 A CA2047723 A CA 2047723A CA 2047723 A1 CA2047723 A1 CA 2047723A1
Authority
CA
Canada
Prior art keywords
compound
inhibin
antibodies
embryo
ova
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047723A
Other languages
English (en)
French (fr)
Inventor
Stefan Heiden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2047723A1 publication Critical patent/CA2047723A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002047723A 1990-01-08 1991-01-04 Compound for improving the ovary reactions and the ova and embryo production in domestic mammals in combination with biotechnological embryo transfer Abandoned CA2047723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4000327.2 1990-01-08
DE4000327A DE4000327A1 (de) 1990-01-08 1990-01-08 Arzneimittel zur verbesserung der ovarreaktion und der eizell- und embryonen- produktion bei haussaeugetieren

Publications (1)

Publication Number Publication Date
CA2047723A1 true CA2047723A1 (en) 1991-07-09

Family

ID=6397731

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047723A Abandoned CA2047723A1 (en) 1990-01-08 1991-01-04 Compound for improving the ovary reactions and the ova and embryo production in domestic mammals in combination with biotechnological embryo transfer

Country Status (5)

Country Link
EP (1) EP0463138B1 (https=)
AU (1) AU649994B2 (https=)
CA (1) CA2047723A1 (https=)
DE (3) DE4042408C2 (https=)
WO (1) WO1991010449A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4042408C2 (de) * 1990-01-08 1995-04-06 Stefan Heiden Verwendung von Inhibin- neutralisierenden Antikörpern
JP2899534B2 (ja) * 1994-12-09 1999-06-02 全国農業協同組合連合会 牛の過剰排卵誘起方法
US20240317845A1 (en) * 2021-12-15 2024-09-26 Ningbo Sansheng Biological Technology Co., Ltd. Antibody against inhibin and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
AU4437485A (en) * 1984-06-08 1986-01-10 Biotechnology Australia Proprietary Limited Inhibin isolated from ovarian follicular fluid
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
WO1988000208A1 (en) * 1986-06-24 1988-01-14 The Salk Institute For Biological Studies Ovine inhibin
US4780451B1 (en) * 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
DE4042408C2 (de) * 1990-01-08 1995-04-06 Stefan Heiden Verwendung von Inhibin- neutralisierenden Antikörpern

Also Published As

Publication number Publication date
AU649994B2 (en) 1994-06-09
EP0463138B1 (de) 1994-05-11
DE4000327C2 (https=) 1992-07-02
DE59101599D1 (de) 1994-06-16
EP0463138A1 (de) 1992-01-02
AU7055291A (en) 1991-08-05
WO1991010449A1 (de) 1991-07-25
DE4000327A1 (de) 1991-07-11
DE4042408C2 (de) 1995-04-06

Similar Documents

Publication Publication Date Title
JP6419707B2 (ja) 卵胞同期化後の単回リコンビナントウシｆｓｈ
US4959354A (en) Mixtures of FSH and LH from pig hypophyses in a definite ratio
US11299527B2 (en) Long-acting recombinant porcine FSH fusion protein and preparation method and application thereof
JPH01502669A (ja) 精製された血小板由来の成長因子及びその精製方法
TW200846361A (en) Expression and bioactivity of bovine follicle stimulating hormone
US20240317845A1 (en) Antibody against inhibin and use thereof
SK287041B6 (sk) Spôsob čistenia luteinizačného hormónu - LH zo vzorky, rekombinantný hLH, jeho použitie a farmaceutický prostriedok s jeho obsahom
CA2047723A1 (en) Compound for improving the ovary reactions and the ova and embryo production in domestic mammals in combination with biotechnological embryo transfer
KR890011611A (ko) 단일클론성 항체
JP2000508293A (ja) Ｆｓｈ作用の促進に有用な新規なペプチド
US20240199754A1 (en) Applications of GHR-106 Monoclonal Antibody as a GnRH Antagonist
Booman et al. A comparative study on the use of bovine and murine monoclonal antibodies for passive immunization in cattle
RU2038780C1 (ru) Способ стимуляции репродуктивной функции коров
JPS63503141A (ja) 動物の生殖機能の調節方法
JPH08154957A (ja) 牛の過剰排卵誘起方法
CA3065112C (en) Long-acting recombinant porcine fsh fusion protein, and preparation method and application thereof
Ruginosu et al. Searches on the application of a method of induction and syncronization of estrus in cows postpartum based on two doses of GnRH and prostaglandin F2 α, with programmed insemination
Scaramuzzi et al. The implications of immunological techniques for the improvement of production efficiency in pigs.
RU2024128835A (ru) Стимуляция суперовуляции у bos taurus
BR112024000308B1 (pt) Anticorpo anti-inibina ou porção de ligação ao antígeno deste, molécula de ácido nucleico, vetor, célula, sistema de expressão in vitro, composição e uso
GB2092156A (en) Process for the production of human thyroid-stimulating hormone
DE102007025107A1 (de) Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung
JPH05501858A (ja) Ｓｒｉｆ関連ペプチドおよびそれらの使用
Danner Efficacy of an equine pituitary extract to superovulate cows.
Counis et al. Cell-Free Synthesis of Rat Lutropin Subunits

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20040105